Literature DB >> 16638627

Distribution of glutathione S-transferase M1, P1 and T1 genotypes in different age-groups of Finns without diagnosed cancer.

Anu Voho1, Olli Impivaara, Jorma Järvisalo, Katja Metsola, Harri Vainio, Ari Hirvonen.   

Abstract

BACKGROUND: Xenobiotic metabolizing enzymes (XMEs) are important detoxifiers of hazardous environmental agents, and their polymorphisms may therefore modify the risk of environmentally induced cancers. Consequently, the XME polymorphisms have been extensively studied in this context during recent years. Particular attention has been given to the polymorphisms of glutathione S-transferase (GST) M1, P1 and T1 genes. Previous studies have provided abundant data indicating these polymorphisms as important modifiers of individual susceptibility to cancers of environmental origin. It can be postulated that if the at-risk genotypes of these genes were real risk factors for the environmental cancers, their prevalence would presumably decrease with age in cancer-free part of the population.
METHODS: We tested the hypothesis in a population based group of 2105 Finns (1,051 men, 1,054 women) in five age strata (27, 37, 47, 57 and 67 years of age), all without clinically diagnosed cancer.
RESULTS: For GSTM1 genotype, a significant interaction was seen between gender and age among never smokers (p=0.003). Currently smoking men tended to be less likely (OR 0.57, 95% CI 0.31-1.03), and currently smoking women more likely (OR 1.70, 95% CI 0.97-2.97) homozygotes for the GSTP1*B allele compared with never smokers. Moreover, the likelihood of being a concurrent carrier of the putatively protective genotypes of all of the three studied GSTs was almost three-fold (OR 2.80, 95% CI 1.10-7.12) in heavy smokers in the two oldest age-groups compared with the other genotypes.
CONCLUSIONS: Our findings based on a novel study design provide support to the previous case-control studies suggesting that GST genotypes modify individual risk of environmentally-induced cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638627     DOI: 10.1016/j.cdp.2005.11.004

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  6 in total

1.  Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease.

Authors:  Angelika D Wahner; Charles E Glatt; Jeff M Bronstein; Beate Ritz
Journal:  Neurosci Lett       Date:  2006-12-27       Impact factor: 3.046

2.  Vitamin C levels in blood are influenced by polymorphisms in glutathione S-transferases.

Authors:  Alexandra Horska; Csilla Mislanova; Stefano Bonassi; Marcello Ceppi; Katarina Volkovova; Maria Dusinska
Journal:  Eur J Nutr       Date:  2010-12-09       Impact factor: 5.614

3.  Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants: simultaneously detecting GSTM1 and GSTT1 gene copy number and the allelic status of the GSTP1 Ile105Val genetic variant.

Authors:  Anders Buchard; Juan J Sanchez; Kim Dalhoff; Niels Morling
Journal:  J Mol Diagn       Date:  2007-10-04       Impact factor: 5.568

Review 4.  Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.

Authors:  L M Bull; D L White; M Bray; Z Nurgalieva; H B El-Serag
Journal:  Dis Esophagus       Date:  2009-02-13       Impact factor: 3.429

5.  Prevalence of at-risk genotypes for genotoxic effects decreases with age in a randomly selected population in Flanders: a cross sectional study.

Authors:  Hans B Ketelslegers; Roger W L Godschalk; Ralph W H Gottschalk; Ad M Knaapen; Gudrun Koppen; Greet Schoeters; Willy F Baeyens; Vera Nelen; Joep P M Geraedts; Joost H M van Delft; Jos C S Kleinjans; Nicolas A van Larebeke
Journal:  Environ Health       Date:  2011-10-05       Impact factor: 5.984

6.  Association of a deletion of GSTT2B with an altered risk of oesophageal squamous cell carcinoma in a South African population: a case-control study.

Authors:  Marco Matejcic; DongPing Li; Natalie J Prescott; Cathryn M Lewis; Christopher G Mathew; M Iqbal Parker
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.